PFSweb (NASDAQ:PFSW) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Monday, June 3rd, ValuEngine reports. Several other analysts also recently issued reports on the stock. TheStreet downgraded shares of PFSweb from a “c-” rating to a “d” rating in a report on […]
PFSweb (NASDAQ:PFSW) Cut to Sell at ValuEngine Read More »
Protagenic Therapeutics (OTCMKTS:PTIX) and PFSweb (NASDAQ:PFSW) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations. Profitability This table compares Protagenic Therapeutics and PFSweb’s net margins, return on equity and return on
Protagenic Therapeutics (OTCMKTS:PTIX) vs. PFSweb (OTCMKTS:PFSW) Financial Analysis Read More »
PFSweb (NASDAQ:PFSW) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Monday, June 3rd, ValuEngine reports. PFSW has been the subject of a number of other research reports. Needham & Company LLC restated a “buy” rating and issued a $9.00 price target (down
PFSweb (NASDAQ:PFSW) Cut to “Sell” at ValuEngine Read More »
PFSweb (NASDAQ:PFSW) and Protagenic Therapeutics (OTCMKTS:PTIX) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Volatility & Risk PFSweb has a beta of 0.62, indicating that its stock price is
Critical Contrast: PFSweb (NASDAQ:PFSW) and Protagenic Therapeutics (NASDAQ:PTIX) Read More »
PFSweb, Inc. (NASDAQ:PFSW) was the target of a significant increase in short interest in May. As of May 31st, there was short interest totalling 876,900 shares, an increase of 47.1% from the April 30th total of 596,300 shares. Approximately 6.2% of the company’s stock are sold short. Based on an average trading volume of 76,000
PFSweb, Inc. (NASDAQ:PFSW) Sees Significant Increase in Short Interest Read More »
Alambic Investment Management L.P. grew its stake in PFSweb, Inc. (NASDAQ:PFSW) by 74.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 124,198 shares of the business services provider’s stock after purchasing an additional 53,096 shares during the period. Alambic Investment
PFSweb, Inc. (NASDAQ:PFSW) Position Raised by Alambic Investment Management L.P. Read More »
PFSweb (NASDAQ:PFSW) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Monday, ValuEngine reports. Other research analysts have also recently issued reports about the stock. Craig Hallum cut shares of PFSweb from a “buy” rating to a “hold” rating in a report on Tuesday, March
ValuEngine Downgrades PFSweb (PFSW) to Sell Read More »
Protagenic Therapeutics (OTCMKTS:PTIX) and PFSweb (NASDAQ:PFSW) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk. Insider and Institutional Ownership 57.7% of PFSweb shares are held by institutional investors. 51.1% of Protagenic
PFSweb (PFSW) versus Protagenic Therapeutics (PTIX) Financial Review Read More »
Deutsche Bank AG lessened its holdings in shares of PFSweb, Inc. (NASDAQ:PFSW) by 66.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 43,057 shares of the business services provider’s stock after selling 84,769 shares during the period. Deutsche Bank AG owned approximately 0.22% of PFSweb worth $220,000
PFSweb, Inc. (PFSW) Shares Sold by Deutsche Bank AG Read More »
TheStreet cut shares of PFSweb (NASDAQ:PFSW) from a c- rating to a d rating in a report issued on Friday, May 10th, TheStreetRatingsTable reports. A number of other research firms have also issued reports on PFSW. Craig Hallum lowered shares of PFSweb from a buy rating to a hold rating in a research note on
PFSweb (NASDAQ:PFSW) Downgraded by TheStreet Read More »
